06/18/2025 08:38
SINOVAC Announces New Board Member

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a resignation notice from David Guowei Wang, a member of the board of directors (the “Board”) and a member of the Audit Committee, Compensation Committee and the Corporate Governance and Nominating Committee of the Board, effective immediately. Mr. Wang’s resignation was due to increased professional commitments and time constraints and was...

07/07/2025 12:00
AHF Webinar Panel Discussion—Pandemic Prevention, Preparedness, and Response After the Agreement: What Comes Next?

AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Pandemic Prevention, Preparedness, and Response After the Agreement: What Comes Next?,” on Tuesday, July 8 at 10:00 AM EDT, virtually via Zoom. Register here. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707205332/en/ This timely webinar will explore the future of global pandemic governance following...

07/07/2025 12:00
Accellix Appoints Dr. Félix A. Montero-Julian as Vice President of Scientific Affairs

Accellix, a global leader in rapid point of need cytometry solutions, is pleased to announce the appointment of Félix A. Montero-Julian, PhD as Vice President of Scientific Affairs. Dr. Montero-Julian brings more than 30 years of international experience in scientific affairs, analytical development, and regulatory science to support Accellix’s strategic vision and innovation roadmap. Dr. Montero-Julian joins Accellix from bioMérieux, where he most recently served as Scientific Senior Directo...